ENDPOINTS

Bluebird gets new M&A bid, seeking to top private equity offer

A rival group is seeking to buy cell therapy biotech bluebird bio, in an effort to outbid a private equity offer by Carlyle and SK Capital, according to people familiar with the matter. The rival ...

Mar 28, 2025 - 20:53
 0
Bluebird gets new M&A bid, seeking to top private equity offer
A rival group is seeking to buy cell therapy biotech bluebird bio, in an effort to outbid a private equity offer by Carlyle and SK Capital, according to people familiar with the matter. The rival ...
Read More

Tags:

Previous Article

What Caused the Magnitude 7.7 Myanmar and Thailand Earthquake?

Next Article

Fewer kids are choking on coins—digital payments may be why

Related Posts

OpenAI meets cancer care

OpenAI meets cancer care

Feb 27, 2025  0

Walgreens to go private in $10B deal

Walgreens to go private in $10B deal

Mar 6, 2025  0

AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in China

AstraZeneca puts $2.5B toward first vaccine factory and...

Mar 21, 2025  0